Why the study?
Do low molecular weight heparins reduce the incidence of DVT and PE in patients undergoing surgery compared to placebo, dextran, or unfractionated heparin?
Do low molecular weight heparins reduce the incidence of DVT and PE in patients undergoing surgery compared to placebo, dextran, or unfractionated heparin?
LMWHs are effective for thromboprophylaxis in high-risk orthopaedic surgery patients, but evidence is inconclusive for their superiority over unfractionated heparin in general surgery.
Answers are grounded in this paper and cite their sources.
LMWH prophylaxis should be prioritized in high-risk orthopaedic surgery; confirms DVT reduction versus comparators but leaves open superiority over UFH in general surgery.
Objective: To examine the effectiveness of low molecular weight heparins (LMWHs) in the prevention and treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) following surgery. Design: A review of the results of randomized controlled trials of LMWHs in which LMWH was compared with placebo, dextran or unfractionated heparin. Methods: Published data from journals indexed in Index Medicus (Medline CD Rom) since 1984 or found in the reference lists of such journals. Main outcome measures: Incidence of DVT as assessed by isotope scanning and/or venography and the incidence of PE and bleeding complications. Results: Prophylaxis with LMWH causes a significant reduction in the incidence of DVT compared with placebo, dextran and unfractionated heparin in high-risk patients undergoing orthopaedic operations, but there is no conclusive evidence that they are better than unfractionated heparin in general surgery. There was inconclusive evidence that LMWHs reduced the incidence of PE compared with dextran or unfractionated heparin. LMWHs were at least as safe as unfractionated heparin in terms of major haemorrhage or postoperative blood loss. Conclusions: Current evidence suggests the use of LMWHs in high-risk orthopaedic patients as a means of thromboprophylaxis is cost-effective. More trials are necessary to justify the use of LMWHs over unfractionated heparin in general surgery.
No takes yet. Share an insight, caveat, or question.
Andaz et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: